Liver MRI scatter correction study
Part of Digestive system clinical trials.
This study tests a new way to improve liver MRI images by reducing scatter. It includes healthy volunteers and patients with fatty liver disease (steatosis) having a regular liver MRI.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are a healthy volunteer or a patient with fatty liver on a recent MRI
- Healthy volunteers work at the Royal Marsden or Institute of Cancer Research
- You are not being investigated for an undiagnosed condition (healthy volunteers)
- You do not have severe liver scarring (cirrhosis) (patients)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new type of MRI scan can better detect and measure liver disease, including fatty liver and scarring, compared to standard CT scans. If you have chronic liver disease, this study may help improve how we diagnose and track it.
This study uses advanced MRI scans to get a clearer picture of liver fat, inflammation, and scarring in people with chronic liver disease. It aims to help doctors diagnose and understand liver problems better.
This study uses a new MRI technique to look at blood flow and iron in the liver, without needing a biopsy. It tests how well this newer imaging method works in people with liver disease and in healthy volunteers, to help improve diagnosis and monitoring.
This study tests a new ultrasound method to classify fatty liver disease, which might offer a safer and cheaper alternative to MRI. It compares ultrasound results with MRI in healthy people and those with liver disease to see if it can accurately measure liver fat and scarring.
This study is testing whether an MRI can help doctors see liver scarring (fibrosis) in people with MASLD, a type of fatty liver disease. It is for patients who already need a liver biopsy as part of their care, to compare the MRI results with the biopsy.
This study tests whether a special MRI scan (called 4D-MRI) can identify liver scarring or damage. It may help doctors measure liver fibrosis and inflammation without relying only on invasive tests.
Hear when a new Steatohepatitis, Nonalcoholic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.